ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)

JPY 2041.0

(-0.34%)

Market Cap (In JPY)

57.89 Billion

Revenue (In JPY)

62.84 Billion

Net Income (In JPY)

7.54 Billion

Avg. Volume

60.12 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1712.0-2720.0
PE
-
EPS
-
Beta Value
0.442
ISIN
JP3119660003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Takashi Yamaguchi
Employee Count
-
Website
https://www.aska-pharma-hd.co.jp
Ipo Date
2021-04-01
Details
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.